Effect of Pulmonary Rehabilitation Program on Patients With Acute Ischemic Stroke, Mortality and Disability
NCT ID: NCT04110652
Last Updated: 2019-12-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2019-02-03
2020-01-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Inclusion criteria:
* Adult (≥18 years old).
* With Acute Ischemic Stroke.
Exclusion criteria:
* Hemorrhagic stroke.
* GCS \< 7 on admission.
* Clinical signs of infection on admission.
* Significant pulmonary disease, angina, myocardial infarction or acute heart failure within three months.
For every eligible patient the following data will be collected:
* Demographic data including age \& sex.
* Vital signs.
* Glasgow Coma Score on admission after primary respiratory and hemodynamic stabilization.
* Stroke severity on admission assessed by the National Institute of Health Stroke Scale (NIHSS).
* All patients will undergo a CT scan of the brain on admission. Diagnostic procedures such as Doppler ultrasound of the carotid arteries, MRI, and echocardiography will be ordered if deemed necessary by the treating physician.
* Stroke subtype classification utilizing both the TOAST (Trial of ORG 10172 in Acute Stroke Treatment) method and The Oxfordshire Community Stroke Project.
* Pre-existing comorbid conditions (any treatment and/or patient's self-report): Hypertension, Diabetes Mellitus, Atrial Fibrillation, COPD, CHF, and Current Smoking.
* Evidence for any type of dysphagia documented by a standardized dysphagia screening test.
* Laboratory data: White Blood Cell (WBC) Count, C-reactive Protein (CRP), and Blood Glucose will be done daily.
Grouping The patients will be randomized into 2 groups by conventional method of randomization where patients in group 1 (control group) will be selected in odd numbers and those in group 2 (patients receiving pulmonary rehabilitation program) will be selected in even numbers.
Stroke management Group 1: (Control group) 40 patients will receive Stroke management based on the guidelines of the American Heart Association/American Stroke Association.
Group 2: (Patients receiving pulmonary rehabilitation program) 40 patients will receive Stroke management based on the guidelines of the American Heart Association/American Stroke Association in addition to pulmonary rehabilitation program.
Enrolled patients will be prospectively followed up for:
1. Primary outcome:
• The diagnosis of pneumonia within the first 7 days after admission. (Diagnosis will be made according to modified criteria of the CDC
2. Secondary outcome:
* In-hospital or 30 days mortality.
* Modified Rankin Scale (mRS) at one month.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patient
40 patients with acute stroke will receive Stroke management based on the guidelines of the American Heart Association/American Stroke Association.(20-22) in addition to pulmonary rehabilitation program.
pulmonary rehabilitation program
The pulmonary rehabilitation program consisting of inspiratory muscle training, manual hyperinflation. chest wall mobilization, rib-cage compression, cough function training, postural drainage and secretion removal will be applied to patient group.
The program will be conducted by physical therapists for 30-45 minutes daily during ICU stay.
The exercise intensity will be increased gradually over the course. Each patient's performance during the exercise sessions will be recorded and reported regularly.
control group
40 patients with acute stroke will receive Stroke management based on the guidelines of the American Heart Association/American Stroke Association.
pulmonary rehabilitation program
The pulmonary rehabilitation program consisting of inspiratory muscle training, manual hyperinflation. chest wall mobilization, rib-cage compression, cough function training, postural drainage and secretion removal will be applied to patient group.
The program will be conducted by physical therapists for 30-45 minutes daily during ICU stay.
The exercise intensity will be increased gradually over the course. Each patient's performance during the exercise sessions will be recorded and reported regularly.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pulmonary rehabilitation program
The pulmonary rehabilitation program consisting of inspiratory muscle training, manual hyperinflation. chest wall mobilization, rib-cage compression, cough function training, postural drainage and secretion removal will be applied to patient group.
The program will be conducted by physical therapists for 30-45 minutes daily during ICU stay.
The exercise intensity will be increased gradually over the course. Each patient's performance during the exercise sessions will be recorded and reported regularly.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* With Acute Ischemic Stroke
Exclusion Criteria
* GCS \< 7 on admission.
* Clinical signs of infection on admission.
* Significant pulmonary disease, angina, myocardial infarction or acute heart failure within three months.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mohamed Wahid Elsayed Elsayed
UNKNOWN
Prof. Dr. Tamer Abdullah Helmy
UNKNOWN
Dr. Osama Saeed Hassan
UNKNOWN
Alexandria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rehab Abdelaal ELnemr
lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rehab Abdelaal ELnemr
Alexandria, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Rehab A ELnemr, lecturer
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0105838
Identifier Type: -
Identifier Source: org_study_id